From: Role of MRI in diagnosis of prostate cancer and correlation of results with transrectal ultrasound guided biopsy “TRUS”
MRI MRS
Biopsy
Total
Malignant
Benign
Positive/ non-specific
20 (66.7%) TP
3 (10.0%) FP
23 (76.7%)
Negative
2 (6.6%) FN
5 (16.7%) TN
7 (23.3%)
22 (73.3%)
8 (26.7%)
30 (100.0%)
Kappa (95% CI)
0.556 (0.213–0.900)
P
0.002*